New Molecular Targets of Anticancer Therapy - Current Status and Perspectives.

  title={New Molecular Targets of Anticancer Therapy - Current Status and Perspectives.},
  author={M. Zajac and I. Muszalska and A. Jelińska},
  journal={Current medicinal chemistry},
  volume={23 37},
Molecularly targeted anticancer therapy involves the use of drugs or other substances affecting specific molecular targets that play a part in the development, progression and spread of a given neoplasm. By contrast, the majority of classical chemotherapeutics act on all rapidly proliferating cells, both healthy and cancerous ones. Target anticancer drugs are designed to achieve a particular aim and they usually act cytostatically, not cytotoxically like classical chemotherapeutics. At present… Expand
Discovery and cellular stress pathway analysis of 1,4-naphthoquinone derivatives with novel, highly potent broad-spectrum anticancer activity
The data suggest that Pyr-1 derives its greatly enhanced antitumor activity via mimicking ROS-induced stress signaling without generating ROS, and likely committing cells to autophagy, and these compounds have promising therapeutic potential. Expand
In vivo effects of chemotherapy on oncogenic pathways in colorectal cancer
It is shown that colon cancer cells with high WNT, MAPK and NOTCH activity are variably affected but generally persist in xenograft tumors under different chemotherapeutic regimens, indicating limited effects of cytotoxic therapy on oncogenic signaling pathways. Expand
Accumulated cytotoxicity of CDK inhibitor dinaciclib with first-line chemotherapy drugs in salivary adenoid cystic carcinoma cells
As expected, CDK inhibitor dinaciclib significantly induced ACC-2 cells apoptosis, and it sensitized cells to the chemotherapeutic agents such as cisplatin, pemetrexed, and etoposide (VP-16), and this effect by dinciclib may induce cell cycle arrest via abrogating CDK2 activity. Expand
Combined protein and ligand based physicochemical aspects of molecular recognition for the discovery of CDK9 inhibitor
Abstract CDK9 has the major role in regulating the elongation phase of mRNA transcription by phosphorylation at C-terminal domain of largest sub-unit of RNA polymerase II. Inhibition of CDK9 mediatedExpand
Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment.
Key components of DDR signaling networks may constitute an attractive target for anti-cancer therapy through two distinct potential approaches: as chemoand radiosensitizers to enhance the effectiveness of currently used genotoxic treatment or as single agents to exploit defects in DDR in cancer cells via synthetic lethal approach. Expand
Cadherin Signaling in Cancer: Its Functions and Role as a Therapeutic Target
The mechanisms of cadherin involvement in tumor progression are demonstrated, the clinical significance of Cadherins as therapeutic targets are considered, and cadherins are considered as potential targets for cancer therapies. Expand
Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
This review comprehensively highlights the potentiality of various nanocarriers and nanomedicines for multifaceted applications in diagnostics and drug delivery, especially the potentialities of polymeric nanoparticle, nanoemulsion, solid-lipid nanoparticles, nanostructured lipid carrier, self-micellizing anticancer lipids, dendrimer, nanocapsule and nanosponge-based therapeutic approaches in the field of cancer. Expand
Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence
This review comprehensively describes preclinical studies on chalcones and their derivatives describing their immense significance as antidiabetic, anticancer, anti-inflammatory, antimicrobial, antioxidant, antiparasitic, psychoactive, and neuroprotective agents. Expand
Ultrasound-Targeted Delivery Technology: A Novel Strategy for Tumor- Targeted Therapy.
The results of this study show that ultrasound-targeted delivery technology is a promising therapeutic strategy for tumor treatment, and shows promise with regard to cancer treatment. Expand
A Comprehensive Review on Schisandrin B and Its Biological Properties
The data suggest that the antitumor activities of Sch B were mainly through apoptosis and cell cycle arrest at the diver's stage, and it is reported that Sch B could be used as effective chemotherapy, neuroprotection, and cardioprotection since it possesses a spectrum of biological activities. Expand